197 related articles for article (PubMed ID: 30698680)
1. Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis.
Ntranos A; Ntranos V; Bonnefil V; Liu J; Kim-Schulze S; He Y; Zhu Y; Brandstadter R; Watson CT; Sharp AJ; Katz Sand I; Casaccia P
Brain; 2019 Mar; 142(3):647-661. PubMed ID: 30698680
[TBL] [Abstract][Full Text] [Related]
2. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
van Langelaar J; van der Vuurst de Vries RM; Janssen M; Wierenga-Wolf AF; Spilt IM; Siepman TA; Dankers W; Verjans GMGM; de Vries HE; Lubberts E; Hintzen RQ; van Luijn MM
Brain; 2018 May; 141(5):1334-1349. PubMed ID: 29659729
[TBL] [Abstract][Full Text] [Related]
3. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
Karandikar NJ; Crawford MP; Yan X; Ratts RB; Brenchley JM; Ambrozak DR; Lovett-Racke AE; Frohman EM; Stastny P; Douek DC; Koup RA; Racke MK
J Clin Invest; 2002 Mar; 109(5):641-9. PubMed ID: 11877472
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M
Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461
[TBL] [Abstract][Full Text] [Related]
5. Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters.
Zoghi S; Amirghofran Z; Nikseresht A; Ashjazadeh N; Kamali-Sarvestani E; Rezaei N
Immunol Invest; 2011; 40(6):581-96. PubMed ID: 21510778
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis.
Bos SD; Page CM; Andreassen BK; Elboudwarej E; Gustavsen MW; Briggs F; Quach H; Leikfoss IS; Bjølgerud A; Berge T; Harbo HF; Barcellos LF
PLoS One; 2015; 10(3):e0117403. PubMed ID: 25734800
[TBL] [Abstract][Full Text] [Related]
7. Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.
Sondermann W; Rompoti N; Leister L; Huptas L; Klode J; Dissemond J; Körber A
Dermatology; 2017; 233(4):295-302. PubMed ID: 28954274
[TBL] [Abstract][Full Text] [Related]
8. Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Haarmann A; Nehen M; Deiß A; Buttmann M
Int J Mol Sci; 2015 Aug; 16(8):19086-95. PubMed ID: 26287168
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Tennakoon DK; Mehta RS; Ortega SB; Bhoj V; Racke MK; Karandikar NJ
J Immunol; 2006 Jun; 176(11):7119-29. PubMed ID: 16709875
[TBL] [Abstract][Full Text] [Related]
10. New Insights into Epigenetic Regulation of T Cell Differentiation.
Dutta A; Venkataganesh H; Love PE
Cells; 2021 Dec; 10(12):. PubMed ID: 34943965
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients.
Kiselev I; Danilova L; Baulina N; Baturina O; Kabilov M; Boyko A; Kulakova O; Favorova O
Mult Scler Relat Disord; 2022 Apr; 60():103714. PubMed ID: 35245816
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature.
Coit P; Roopnarinesingh X; Ortiz-Fernández L; McKinnon-Maksimowicz K; Lewis EE; Merrill JT; McCune WJ; Wren JD; Sawalha AH
Ann Rheum Dis; 2022 Oct; 81(10):1428-1437. PubMed ID: 35710306
[TBL] [Abstract][Full Text] [Related]
13. Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action.
Gold R; Linker RA; Stangel M
Clin Immunol; 2012 Jan; 142(1):44-8. PubMed ID: 21414846
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
Kadowaki A; Saga R; Lin Y; Sato W; Yamamura T
Brain; 2019 Apr; 142(4):916-931. PubMed ID: 30770703
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells.
Steinfelder S; Floess S; Engelbert D; Haeringer B; Baron U; Rivino L; Steckel B; Gruetzkau A; Olek S; Geginat J; Huehn J; Hamann A
Blood; 2011 Mar; 117(10):2839-46. PubMed ID: 21228329
[TBL] [Abstract][Full Text] [Related]
16. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dendritic cell differentiation by fumaric acid esters.
Zhu K; Mrowietz U
J Invest Dermatol; 2001 Feb; 116(2):203-8. PubMed ID: 11179994
[TBL] [Abstract][Full Text] [Related]
18. Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis.
Höxtermann S; Nüchel C; Altmeyer P
Dermatology; 1998; 196(2):223-30. PubMed ID: 9568412
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages.
Zhang Z; Butler R; Koestler DC; Bell-Glenn S; Warrier G; Molinaro AM; Christensen BC; Wiencke JK; Kelsey KT; Salas LA
Clin Epigenetics; 2022 Dec; 14(1):173. PubMed ID: 36522672
[TBL] [Abstract][Full Text] [Related]
20. [Genome-Wide Analysis of DNA Methylation in Cd4+ T Lymphocytes of Patients with Primary Progressive Multiple Sclerosis Indicates Involvement of This Epigenetic Process in the Disease Immunopathogenesis].
Kiselev IS; Kulakova OG; Danilova LV; Baturina OA; Kabilov MR; Popova EV; Boyko AN; Favorova OO
Mol Biol (Mosk); 2022; 56(3):468-475. PubMed ID: 35621102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
